CoreCap Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CoreCap Advisors's GILD Position: Q3 2026 in Review
CoreCap Advisors reduced its Gilead Sciences (GILD) stake by 95% in Q3 2026, selling an estimated $6.24M and leaving 2,158 shares worth $322K. The position accounts for 0.01% of the portfolio, ranked #693.
CoreCap Advisors first reported a position in GILD in Q4 2021 and has held it in 15 quarters since. The position peaked at $5.89M in Q2 2026. 664 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- CoreCap Advisors held 2,158 shares of Gilead Sciences worth $322K as of Q3 2026.
- CoreCap Advisors sold 44,466 Gilead Sciences shares in Q3 2026, an estimated $6.24M.
- Gilead Sciences made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #693 holding.
- CoreCap Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 15 quarters since.
- CoreCap Advisors's Gilead Sciences position peaked at $5.89M in Q2 2026.
- 664 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.